Kazia Therapeutics to Present at HC Wainwright 23rd Annual Global Investment Conference
/PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce that CEO, Dr James...
admin
0
4
/PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce that CEO, Dr James...
.jpg)
.jpeg)
.jpeg)